Keywords: vectura, inhaled, pd, drug, impresses, ph, ii

Vectura's inhaled PD drug impresses at Ph II

Article | 12 November 2007

Print This

UK-based pulmonary drug developer Vectura says that it has achieved positive results in a Phase II trial of its developmental ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in